All In Biotech

Drug Trial Radar · NCT01531192

Comparison of Lactobacillus Reuteri and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants

Zekai Tahir Burak Maternity Teaching Hospital, Ankara/Turkey

Last checked: Nov 19, 2026Latest source record: Jul 16, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

300

Actual

Start

Jun 2012

Primary completion

Apr 2013

Study completion Apr 2013

Sponsor

Sponsor type
Academic, hospital or other
First posted
Feb 10, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Prevention
Who can join
All sexes, from 1 day, up to 6 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Probiotics are favorable microorganisms that regulate the flora of the gastrointestinal system and stimulate the immune system. Lactobacillus reuteri was shown to reduce candida colonization. The objective of this study is to evaluate the efficacy of prophylactic Lactobacillus reuteri in reducing the candida colonization and infection in very low birth weight infants.

Conditions

  • Very Low Birth Weight Infants

Interventions

  • Lactobacillus reuteriDietary supplement

    Lactobacillus reuteri 100 million CFU/day for 3 months

  • NystatinDrug

    50000 unit/3 times a day, both for orally and by orogastric route

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Comparison of prophylactic Lactobacillus reuteri and nystatin on candida colonization and infection in very low birth weight infantsTime frame: up to 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Zekai Tahir Burak Maternity Teaching Hospital, Division of Neonatology

    Ankara, Turkey (Türkiye)

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.